焦虑症和忧郁症治疗市场－全球产业规模、份额、趋势、机会和预测，按产品、适应症、地区和竞争格局划分，2020-2030年预测

2024年全球焦虑症和忧郁症治疗市场规模为112.7亿美元，预计到2030年将以5.93%的复合年增长率增长至159.2亿美元。全球焦虑症和忧郁症治疗市场涵盖一系列药物干预措施，包括抗忧郁药物、抗焦虑药物和情绪稳定剂，以及各种心理治疗方法和神经刺激技术，旨在缓解症状并改善患有这些普遍存在的精神健康问题的患者的预后。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球焦虑症与忧郁症治疗市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 副产品（抗忧郁药物、疗法和器械，其他）
  • 依适应症（强迫症、重度忧郁症、恐惧症、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美焦虑症与忧郁症治疗市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲焦虑症与忧郁症治疗市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区焦虑症与忧郁症治疗市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲焦虑症和忧郁症治疗市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲焦虑症与忧郁症治疗市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球焦虑症与忧郁症治疗市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Abbvie Inc.
• Bristol-Myers Squibb Company
• Eli Lily & Co
• GlaxoSmithKline Plc
• H. Lundbeck A/S
• Johnson & Johnson Services, Inc.
• Merck & Co. Inc
• Pfizer Inc
• Sanofi
• Axsome Therapeutics Inc

第十六章：策略建议

第17章调查会社について・免责事项

The Global Anxiety Disorders and Depression Treatment Market, valued at USD 11.27 Billion in 2024, is projected to experience a CAGR of 5.93% to reach USD 15.92 Billion by 2030. The Global Anxiety Disorders and Depression Treatment Market encompasses a range of pharmacological interventions, including antidepressants, anxiolytics, and mood stabilizers, alongside various psychotherapeutic modalities and neurostimulation techniques designed to alleviate symptoms and improve outcomes for individuals suffering from these pervasive mental health conditions.

Key Market Drivers

The Global Anxiety Disorders and Depression Treatment Market is significantly influenced by the escalating worldwide incidence of mental health conditions and ongoing innovations in therapeutic strategies. The rising global prevalence of anxiety and depression disorders directly expands the addressable patient population requiring interventions, thereby acting as a fundamental growth catalyst for the market. This demographic shift necessitates broader access to diagnostic tools and diverse treatment options.

Key Market Challenges

The substantial economic burden linked to developing and delivering novel therapeutic solutions directly impedes the growth of the Global Anxiety Disorders and Depression Treatment Market. The extensive research and development phases for new antidepressants, anxiolytics, and advanced neurostimulation techniques necessitate considerable financial investment. These high costs ultimately translate into elevated pricing for new treatments, making them less accessible, particularly in regions with limited healthcare budgets and less developed infrastructure.

Key Market Trends

The expansion of digital therapeutics and telehealth solutions significantly influences the anxiety disorders and depression treatment market by enhancing accessibility and scalability of care. These platforms leverage technology to deliver evidence-based interventions remotely, reaching a broader patient population, particularly in underserved areas. According to GSMA's Mobile Economy 2024 report, approximately 5.6 billion people worldwide were mobile service subscribers in 2023, providing a vast infrastructure for these digital health services.

Key Market Players

• Abbvie Inc.
• Bristol-Myers Squibb Company
• Eli Lily & Co
• GlaxoSmithKline Plc
• H. Lundbeck A/S
• Johnson & Johnson Services, Inc.
• Merck & Co. Inc
• Pfizer Inc
• Sanofi
• Axsome Therapeutics Inc

Report Scope:

In this report, the Global Anxiety Disorders and Depression Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anxiety Disorders and Depression Treatment Market, By Product:

• Antidepressant Drugs
• Therapy and Devices
• Others

Anxiety Disorders and Depression Treatment Market, By Indication:

• Obsessive-Compulsive Disorder
• Major Depressive Disorder
• Phobia
• Others

Anxiety Disorders and Depression Treatment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Anxiety Disorders and Depression Treatment Market.

Available Customizations:

Global Anxiety Disorders and Depression Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Anxiety Disorders and Depression Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Antidepressant Drugs, Therapy and Devices, Others)
  • 5.2.2. By Indication (Obsessive-Compulsive Disorder, Major Depressive Disorder, Phobia, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Anxiety Disorders and Depression Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Indication
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Anxiety Disorders and Depression Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Indication
  • 6.3.2. Canada Anxiety Disorders and Depression Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Indication
  • 6.3.3. Mexico Anxiety Disorders and Depression Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Indication

7. Europe Anxiety Disorders and Depression Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Indication
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Anxiety Disorders and Depression Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Indication
  • 7.3.2. France Anxiety Disorders and Depression Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Indication
  • 7.3.3. United Kingdom Anxiety Disorders and Depression Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Indication
  • 7.3.4. Italy Anxiety Disorders and Depression Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Indication
  • 7.3.5. Spain Anxiety Disorders and Depression Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Indication

8. Asia Pacific Anxiety Disorders and Depression Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Indication
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Anxiety Disorders and Depression Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Indication
  • 8.3.2. India Anxiety Disorders and Depression Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Indication
  • 8.3.3. Japan Anxiety Disorders and Depression Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Indication
  • 8.3.4. South Korea Anxiety Disorders and Depression Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Indication
  • 8.3.5. Australia Anxiety Disorders and Depression Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Indication

9. Middle East & Africa Anxiety Disorders and Depression Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Indication
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Anxiety Disorders and Depression Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Indication
  • 9.3.2. UAE Anxiety Disorders and Depression Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Indication
  • 9.3.3. South Africa Anxiety Disorders and Depression Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Indication

10. South America Anxiety Disorders and Depression Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Indication
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Anxiety Disorders and Depression Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Indication
  • 10.3.2. Colombia Anxiety Disorders and Depression Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Indication
  • 10.3.3. Argentina Anxiety Disorders and Depression Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Indication

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Anxiety Disorders and Depression Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbvie Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bristol-Myers Squibb Company
• 15.3. Eli Lily & Co
• 15.4. GlaxoSmithKline Plc
• 15.5. H. Lundbeck A/S
• 15.6. Johnson & Johnson Services, Inc.
• 15.7. Merck & Co. Inc
• 15.8. Pfizer Inc
• 15.9. Sanofi
• 15.10. Axsome Therapeutics Inc

16. Strategic Recommendations

17. About Us & Disclaimer